A new market report published by Leafreport, in partnership with Las Vegas’ Canalysis Laboratories, measured the accuracy of CBD-content claims on a sample of 37 hemp-derived CBD products.
Photo © AdobeStock.com/Elroi
A new market report published by Leafreport, in partnership with Las Vegas’ Canalysis Laboratories, measured the accuracy of CBD-content claims on a sample of 37 hemp-derived CBD products. Most of these were CBD oil tinctures, but some were edibles, topicals, and pet products, states the report. Results of the third-party CBD tests showed that out of the 37 products, 27 (73%) contained CBD levels within 10% of the claims amount. Five products (13%) had variation in CBD content greater than 30% from their labeled content. Two products contained less than the stated amount, while 3 contained more than the stated amount.
The report graded the products on a scale of A-F. Of the remaining products, four products (11%) has CBD content within 20% of the labeled content, resulting in a grade of B, and one product (3%) was within 30% of their labeled CBD content, resulting in a grade of C. Interestingly, 84% of the CBD products contain more CBD than stated on the labeled, rather than less. The report also showed that 12 (33%) of the products also has significant levels of other cannabinoids besides CBD, a sign of quality.
“These findings suggest that the CBD industry is becoming more mature and transparent, resulting in accurate, higher quality products,” explained Noa Gans, head of product at LeafReport.com. Indeed, there are a number of reputable products and brands on the market that utilize independent third-party testing, but consumers should continue to be wary of lesser-known brands as those have been proven to not have the consistency in quality.
OmniActive partners with CRN to raise awareness about macular carotenoids for prenatal health
May 6th 2024OmniActive Health Technologies has announced a partnership with the Council for Responsible Nutrition to educate and raise awareness about the role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy among obstetricians, gynecologists, and other maternal healthcare practitioners.
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.